M. Pfaller

Infectious Diseases · 2001–2019

A researcher in the Science corpus: 13 papers; trusts 10 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Infectious Diseases — 83 citations into it; #90 of 589 by trust here, #127 by citations
• Epidemiology — 71 citations into it; #405 of 2,148 by trust here, #703 by citations
• Applied Microbiology and Biotechnology — 13 citations into it
• Small Animals — 13 citations into it; #456 of 462 by trust here, #377 by citations
• Cell Biology — 11 citations into it
• Clinical Biochemistry — 6 citations into it

Whom M. Pfaller trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Diekema
2. C. León
3. D. Trofa
4. M. Morrell
5. T. Walsh
6. J. Perfect
7. D. Kontoyiannis
8. Georgios Chamilos
9. Victoria J. Fraser
10. S. Ruiz-Santana

Who trusts M. Pfaller overall

1. J. Guinea
2. D. Diekema
3. François L. Mayer
4. K. E. Pristov
5. J. Turnidge
6. Pradnya S. Chavan
7. M. Nucci
8. Mariana Castanheira
9. J. Perfect
10. D. Trofa

Papers from M. Pfaller's perspective

Ordered by how strongly the researchers M. Pfaller trusts endorse each paper. Same corpus, a different order for every researcher.

1. Attributable mortality of nosocomial candidemia, revisited. (Clinical Infectious Diseases)
2. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. (Clinical Infectious Diseases)
3. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
4. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (Clinical Microbiology Reviews)
5. Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality (Antimicrobial Agents and Chemotherapy)
6. Comparison of caspofungin and amphotericin B for invasive candidiasis. (New England Journal of Medicine)
7. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. (Clinical Infectious Diseases)
8. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (New England Journal of Medicine)
9. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. (Clinical Infectious Diseases)
10. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. (Clinical Infectious Diseases)

Their papers

• Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 (2019) — 718 citations
• Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. (2013) — 757 citations
• Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. (2012) — 913 citations
• Epidemiology of Invasive Mycoses in North America (2010) — 929 citations
• Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion (2010) — 759 citations
• Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard (2008) — 3,464 citations
• Reference method for broth dilution antifungal susceptibility testing of yeasts : Third informational supplement (2008) — 674 citations
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) — 4,086 citations
• Aspergillus, Fusarium, and other opportunistic moniliaceous fungi. (2006) — 116 citations
• Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus (2004) — 735 citations
• Attributable mortality of nosocomial candidemia, revisited. (2003) — 1,182 citations
• Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. (2002) — 719 citations
• Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. (2001) — 1,504 citations